Research ArticleClinical Studies
Pegfilgrastim Maintains Relative Dose Intensity and Decreases Hospitalisations in Patients With Endometrial Cancer
KENRO CHIKAZAWA, KEN IMAI, TAKAKI ITO, AZUSA KIMURA, KO HIROYOSHI, YOKOTA MIHO, TOMOYUKI KUWATA and RYO KONNO
In Vivo November 2020, 34 (6) 3669-3673; DOI: https://doi.org/10.21873/invivo.12214
KENRO CHIKAZAWA
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
KEN IMAI
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
TAKAKI ITO
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
AZUSA KIMURA
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
KO HIROYOSHI
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
YOKOTA MIHO
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
TOMOYUKI KUWATA
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
RYO KONNO
Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan
In this issue
In Vivo
Vol. 34, Issue 6
November-December 2020
Pegfilgrastim Maintains Relative Dose Intensity and Decreases Hospitalisations in Patients With Endometrial Cancer
KENRO CHIKAZAWA, KEN IMAI, TAKAKI ITO, AZUSA KIMURA, KO HIROYOSHI, YOKOTA MIHO, TOMOYUKI KUWATA, RYO KONNO
In Vivo Nov 2020, 34 (6) 3669-3673; DOI: 10.21873/invivo.12214
Jump to section
Related Articles
- No related articles found.